Levetiracetam Desitin (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This binding modulates vesicle exocytosis, decreasing neuronal hyper‑excitability and limiting the spread of abnormal electrical activity that triggers seizures.

The specific dose of Levetiracetam Desitin is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions without deviation.

Safety data for levetiracetam in pregnancy and lactation are limited. Healthcare providers weigh potential benefits against unknown risks, and the decision to use the medication during pregnancy or while breastfeeding should be made in consultation with a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a favorable safety profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It is often chosen for patients who require a medication with fewer metabolic concerns, though individual response and tolerability vary.

Store the tablets at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Levetiracetam Desitin is taken orally, usually with or without food, as directed by the prescriber. The tablets should be swallowed whole with water and not chewed or crushed unless specifically advised by a healthcare professional.

Serious adverse events, though rare, include severe allergic reactions such as Stevens‑Johnson syndrome, significant mood changes including depression or suicidal thoughts, and blood disorders like agranulocytosis. Patients should seek immediate medical attention if they experience rash, mood alterations, or signs of infection.

Levetiracetam Desitin is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications that may markedly reduce its efficacy.